RA Capital Management as of Dec. 31, 2010
Portfolio Holdings for RA Capital Management
RA Capital Management holds 19 positions in its portfolio as reported in the December 2010 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ArthroCare Corporation | 9.3 | $11M | 369k | 31.06 | |
| Dynavax Technologies Corporation | 8.6 | $11M | 3.3M | 3.20 | |
| Targacept | 8.6 | $11M | 399k | 26.50 | |
| Sequenom | 8.5 | $11M | 1.3M | 8.03 | |
| OncoGenex Pharmaceuticals | 6.8 | $8.4M | 500k | 16.79 | |
| Jazz Pharmaceuticals | 6.8 | $8.3M | 424k | 19.68 | |
| Alexion Pharmaceuticals | 6.6 | $8.1M | 101k | 80.55 | |
| Pharmasset | 6.5 | $8.1M | 185k | 43.56 | |
| BioSpecifics Technologies | 6.2 | $7.7M | 300k | 25.60 | |
| Onyx Pharmaceuticals | 6.0 | $7.4M | 202k | 36.87 | |
| Biogen Idec (BIIB) | 5.8 | $7.1M | 106k | 67.05 | |
| United Therapeutics Corporation (UTHR) | 5.3 | $6.5M | 103k | 63.22 | |
| Valeant Pharmaceuticals Int | 4.8 | $6.0M | 212k | 28.29 | |
| EXACT Sciences Corporation (EXAS) | 3.4 | $4.2M | 710k | 5.98 | |
| Inhibitex | 2.7 | $3.3M | 1.3M | 2.60 | |
| Columbia Laboratories | 1.9 | $2.3M | 1.0M | 2.27 | |
| XenoPort | 1.8 | $2.3M | 265k | 8.52 | |
| Corcept Therapeutics Incorporated (CORT) | 0.2 | $270k | 70k | 3.86 | |
| Vision-Sciences | 0.1 | $142k | 102k | 1.39 |
